“Breaking records with Cipla’s Q1 success, net profit soars 45% to Rs 996 crore, exceeding expectations!”
Cipla, one of India’s leading pharmaceutical companies, delivered a strong and impressive performance in the first quarter. The company’s net profit rose by 45 per cent, reaching Rs 996 crore, which exceeded analysts’ expectations. Prior forecasts by analysts estimated the net profit to be around Rs 836 crore. The robust growth in Cipla’s net profit […]
Read More